We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Quark Pharmaceuticals Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure

News   Aug 03, 2007

 
Quark Pharmaceuticals Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure
 
 
 

RELATED ARTICLES

Biomedical Bleeding May Impact Horseshoe Crab Spawning Behavior

News

Horseshoe crabs that have undergone biomedical bleeding tend to reside in deeper water and approach mating beaches less often, suggesting the reproductive output of female horseshoe crabs may be compromised during the season in which they were bled.

READ MORE

Embryonic Stem Cells Commit to Their Fate Earlier Than First Thought

News

This study challenges the longstanding assumption that embryonic stem cells remain quite plastic and malleable during the earliest stages of cell commitment.

READ MORE

Switching Embryonic Stem Cells to Neurons to Expose Drug Effects on the Developing Brain

News

A new experimental system has been designed that can rapidly assess the pathogenic effects of a drug on a baby's developing brain. The system uses embryonic stem cells reprogrammed into neurons, and offers a powerful tool for probing genetic and molecular underpinnings of drug-induced neurodevelopmental disorders.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE